Combination therapies in psoriasis
Yıl: 2022 Cilt: 56 Sayı: 1 Sayfa Aralığı: 77 - 79 Metin Dili: İngilizce DOI: 10.4274/turkderm.galenos.2022.77675 İndeks Tarihi: 18-07-2022
Combination therapies in psoriasis
Öz: Topical corticosteroids and vitamin D analogs can be combined with other topical, systemic, and biological agents. The effect of methotrexate
can be enhanced with ultraviolet B (UVB) or psoralen ultraviolet A (PUVA). When a biological agent remains insufficient, the first agent to be
added to the treatment is methotrexate. The use of acitretin in combination with phototherapy (both UVB and PUVA) has a synergistic effect.
A UVB therapy may be combined with topical tar and anthralin as well as with etanercept and adalimumab, which are anti-tumor necrosis
factor-α therapies.
Anahtar Kelime: Psoriasiste kombinasyon tedavileri
Öz: Topikal kortikosteroidler ve vitamin D analogları; diğer topikal tedavilerle, sistemik tedavilerle ve biyolojik ajanlarla kombine edilebilir.
Metotreksatın etkisi ultraviyole B (UVB) veya psoralen ultraviyole A (PUVA) ile artırılabilir. Biyolojik ajan yetersiz kaldığında tedaviye eklenebilecek
ilk sıradaki ajan metotreksattır. Asitretinin fototerapi ile (hem UVB, hem PUVA) ile birlikte kullanımı sinerjistik etkiye sahiptir. UVB tedavisi, topikal
katran ve antralinle ile ve anti-tümör nekroz faktörü-α tedavilerden etanersept ve adalimumab ile kombine edilebilir
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Pathirana D, Ormerod AD, Saiag P, et al.: European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009;23(Suppl2):1-70. Erratum in: J Eur Acad Dermatol Venereol 2010;24:117-8.
- 2. American Academy of Dermatology Work Group; Menter A, Korman NJ, Elmets CA, et al.: Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011;65:137-74.
- 3. Tran B, Feldman SR: Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market. J Dermatolog Treat 2011;22:18-26.
- 4. Staidle JP, Dabade TS, Feldman SR: A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother 2011;12:2041-54.
- 5. Gambichler T, Tigges C, Scola N, et al.: Etanercept plus narrowband ultraviolet B phototherapy of psoriasis is more effective than etanercept monotherapy at 6 weeks. Br J Dermatol 2011;164:1383-6.
- 6. Bagel J: Adalimumab plus narrowband ultraviolet B light phototherapy for the treatment of moderate to severe psoriasis. J Drugs Dermatol 2011;10:366-71.
- 7. Mrowietz U, de Jong EM, Kragballe K, et al.: A consensus report on appropriate treatment optimization and transitioning in the management of moderate-tosevere plaque psoriasis. J Eur Acad Dermatol Venereol 2014;28:438-53.
- 8. Zachariae C, Mørk NJ, Reunala T, et al.: The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy. Acta Derm Venereol 2008;88:495- 501.
- 9. Gisondi P, Del Giglio M, Cotena C, Girolomoni G: Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008;158:1345-9.
- 10. Smith CH, Anstey AV, Barker JN, et al.: British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009;161:987-1019.
- 11. Domm S, Mrowietz U: Combination therapy in the treatment of psoriasis. J Dtsch Dermatol Ges 2011;9:94-8.
- 12. Nakamura M, Koo J: Safety considerations with combination therapies for psoriasis. Expert Opin Drug Saf 2020;19:489-98.
- 13. Bonomo L, Abittan BJ, Hashim PW, Karki C, Mason M, Lebwohl M: Combination use of systemic therapies in psoriasis: baseline characteristics from the corrona psoriasis registry. J Drugs Dermatol 2019;18:731-40.
- 14. Tsai YC, Tsai TF: Switching biologics in psoriasis - practical guidance and evidence to support. Expert Rev Clin Pharmacol 2020;13:493-503.
- 15. Williams VL, Cohen PR: TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Int J Dermatol 2011;50:619-25.
- 16. Wehrmann C, Sondermann W, Körber A: Secukinumab-induced subacutecutaneous lupus erythematosus. Hautarzt 2018;69:64-6.
| APA | KOC E, BÜLBÜL BASKAN E (2022). Combination therapies in psoriasis . , 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| Chicago | KOC EROL,BÜLBÜL BASKAN EMEL Combination therapies in psoriasis . (2022): 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| MLA | KOC EROL,BÜLBÜL BASKAN EMEL Combination therapies in psoriasis . , 2022, ss.77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| AMA | KOC E,BÜLBÜL BASKAN E Combination therapies in psoriasis . . 2022; 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| Vancouver | KOC E,BÜLBÜL BASKAN E Combination therapies in psoriasis . . 2022; 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| IEEE | KOC E,BÜLBÜL BASKAN E "Combination therapies in psoriasis ." , ss.77 - 79, 2022. 10.4274/turkderm.galenos.2022.77675 |
| ISNAD | KOC, EROL - BÜLBÜL BASKAN, EMEL. "Combination therapies in psoriasis ". (2022), 77-79. https://doi.org/10.4274/turkderm.galenos.2022.77675 |
| APA | KOC E, BÜLBÜL BASKAN E (2022). Combination therapies in psoriasis . Türkderm Türk deri hastalıkları ve frengi arşivi, 56(1), 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| Chicago | KOC EROL,BÜLBÜL BASKAN EMEL Combination therapies in psoriasis . Türkderm Türk deri hastalıkları ve frengi arşivi 56, no.1 (2022): 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| MLA | KOC EROL,BÜLBÜL BASKAN EMEL Combination therapies in psoriasis . Türkderm Türk deri hastalıkları ve frengi arşivi, vol.56, no.1, 2022, ss.77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| AMA | KOC E,BÜLBÜL BASKAN E Combination therapies in psoriasis . Türkderm Türk deri hastalıkları ve frengi arşivi. 2022; 56(1): 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| Vancouver | KOC E,BÜLBÜL BASKAN E Combination therapies in psoriasis . Türkderm Türk deri hastalıkları ve frengi arşivi. 2022; 56(1): 77 - 79. 10.4274/turkderm.galenos.2022.77675 |
| IEEE | KOC E,BÜLBÜL BASKAN E "Combination therapies in psoriasis ." Türkderm Türk deri hastalıkları ve frengi arşivi, 56, ss.77 - 79, 2022. 10.4274/turkderm.galenos.2022.77675 |
| ISNAD | KOC, EROL - BÜLBÜL BASKAN, EMEL. "Combination therapies in psoriasis ". Türkderm Türk deri hastalıkları ve frengi arşivi 56/1 (2022), 77-79. https://doi.org/10.4274/turkderm.galenos.2022.77675 |
